Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
INDVthis companyIndivior Pharmaceuticals Inc	$36.28	21.36×	-45.77×	3.62×	15.27×	-92.9%	80.1%	21.4%	16.9%	-214.3%	70.8%	-2.1%	-3.58×	0.51×	5.89×	0.71×	0.0%	7	3.7	2	C+
COLLCollegium Pharmaceutical, Inc.	$24.69	23.38×	4.87×	1.88×	5.38×	2688.6%	59.3%	24.0%	8.1%	20.8%	10.2%	22.3%	3.12×	1.72×	2.27×	1.57×	0.0%	5	0.95	3	B-
SUPNSupernus Pharmaceuticals, Inc.	$27.16	-73.09×	2.64×	3.9×	63.91×	174.6%	89.6%	-5.1%	-5.4%	-3.6%	-2.6%	1.6%	0.04×	-2.06×	0×	1.9×	0.0%	4	5.75	3	B-
Peer median	—	-24.85×	3.75×	2.89×	34.64×	1431.6%	74.5%	9.4%	1.3%	8.6%	3.8%	12.0%	1.58×	-0.17×	1.14×	1.74×	0.0%	5	3.35	3	—